EHA-SWG Scientific Meeting on Integrated Cell Tracking in Oncohematology: Diagnosis, Targeted Therapy and Residual Disease
Dates: November 10-12, 2022
Location: Bordeaux, France
Format: Hybrid
Chair: MC Béné
Registration for on-demand content
PLEASE NOTE: this meeting has passed, but you can still register to receive access to the on-demand recordings of the sessions that took place 10-12 November 2022. The recordings are available until December 12, 2022 (11:59 CET).
This was the third time EHA is collaborating with the EHA Specialized Working Group on Diagnosis in hematological diseases, to bring you the latest in laboratory hematology. The program contained a mixture of expert lectures, patient input and presentations from submitted abstract authors.
Target audience
Senior or junior hematologists, laboratory or clinical, interested in updating their knowledge on the integrated diagnosis of hematological malignancies.
Registration
The meeting has passed, but you can still register to receive access to the recordings of the sessions that took place 10-12 November 2022. To learn more about the registration details, click here.
Program
This meeting covered the following topics related to oncohematology: diagnosis, targeted therapy and residual disease:
- Tools of the trade
- Blast cells
- CD5+ B-lymphocytes
- Lymphoma cells
- CML cells
- Myelodysplastic cells (MDS) and myeloproliferative neoplasms (MPN)
- Other cells
The complete program is available here.
Abstract & case submission
A selection of abstracts were eligible for acceptance during the meeting, the presentation format were in the form of oral presentations or poster presentations.
Abstract submission has closed.
Learning objectives
After attending this EHA-SWG Scientific Meeting, delegates will be able to:
- know about current diagnostic tools,
- understand the targets of treatments,
- understand measurable residual disease,
- get a notion of the necessity of integrated diagnosis, and
- get updated on therapies by other SWG members (clinical).
This meeting is supported by:
Meeting Contributor
EBAH CME Accreditation
Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.
Back